Dear colleagues,

The reduction of health-related risks is an important hallmark in the field of women’s health care. This is of primary interest for contraceptive drugs, which are usually prescribed to healthy women with the sole purpose of avoiding unintended pregnancy. Therefore, the ideal contraceptive would be one that eliminates, or greatly reduces, the risk of harm and adverse events while maintaining a similar efficacy, with many additional possible health benefits for the user. With the latest evolution of contraception technology, many modern hormonal contraceptives—both short and long-acting—meet these prerequisites. The aim of this Special Issue is to highlight the latest discoveries in this broad topic, and to offer clinicians additional safety data for the use of these drugs of daily use.

Dr. Giovanni Grandi
Dr. Maria Chiara del Savio
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• hormonal contraceptives
• pills
• vaginal ring
• patch
• levonorgestrel intrauterine system
• combined hormonal contraceptives
• estradiol
• ethinylestradiol
• progestin
• venous thrombo-embolism
• benefits
• bone
• dysmenorrhea
• metabolism
• lipids
• glucose
• diabetes
• cardiovascular